Get started
Author

Joana Savva-Bordalo

Observed names: J Savva-Bordalo, J. Savva-Bordalo
Institution: IPO Porto
ORCID: 0000-0002-9585-7474
Observed ORCID: 0000-0002-9585-7474
OpenAlex ID: A5028744806
The quest for safe drinking water: An example from Guinea-Bissau (West Africa)
2007 · Adriano A. Bordalo, Joana Savva-Bordalo · Water Research · 94
Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation
2011 · J Savva-Bordalo, C Pinho Vaz, et al. · Bone Marrow Transplantation · 52
Burnout and occupational stress in the medical residents of Oncology, Haematology and Radiotherapy: a prevalence and predictors study in Portugal
2017 · Ana Joaquim, Sandra Custódio, et al. · Psychology Health & Medicine · 39
Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma
2011 · Sara Duarte-Pereira, Filipa Paiva, et al. · European Journal of Cancer · 36
Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations
2013 · João Ramalho-Carvalho, Malini Pires, et al. · PLoS ONE · 34
PDF
Promoter methylation and large intragenic rearrangements of DPYD are not implicated in severe toxicity to 5-fluorouracil-based chemotherapy in gastrointestinal cancer patients
2010 · Joana Savva-Bordalo, João Ramalho-Carvalho, et al. · BMC Cancer · 27
PDF
Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour
2024 · Valéria Tavares, Joana Savva-Bordalo, et al. · Cancers · 13
Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian Cancer
2024 · Valéria Tavares, Joana Savva-Bordalo, et al. · Biomolecules · 11
Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients
2023 · Inês Soares Marques, Valéria Tavares, et al. · International Journal of Molecular Sciences · 10
PDF
Ovarian Real-World International Consortium (ORWIC): A multicentre, real-world analysis of epithelial ovarian cancer treatment and outcomes
2023 · Sue Cheeseman, Bethany Levick, et al. · Frontiers in Oncology · 9
Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes
2024 · Inês Guerra de Melo, Valéria Tavares, et al. · Life · 8
Impact of the COVID-19 Pandemic on Breast Cancer Management in Portugal: A Cross-Sectional Survey-Based Study of Medical Oncologists
2022 · Diogo Alpuim Costa, José Guilherme Gonçalves Nobre, et al. · Oncology and Therapy · 7
PDF
Langerhans cell histiocytosis involving the liver of a male smoker: a case report
2008 · Joana Savva-Bordalo, Margarida Freitas-Silva · Journal of Medical Case Reports · 7
PDF
Consensus on drivers of maintenance treatment choice and patterns of care in advanced ovarian cancer
2024 · Alejandro Perez-Fidalgo, Barbara Schmalfeldt, et al. · International Journal of Gynecological Cancer · 6
Cervical cancer screening opportunities for Guinea-Bissau
2017 · Ivo Julião, Joana Savva-Bordalo, et al. · Porto Biomedical Journal · 5
Heritable Genetic Variability in Ovarian Tumours: Exploring Venous Thromboembolism Susceptibility and Cancer Prognosis in a Hospital-Based Study
2025 · Valéria Tavares, Joana Savva-Bordalo, et al. · Gene · 4
Long-term survival with unmethylated MGMT glioblastoma multiforme
2011 · Joana Savva-Bordalo, André Soares, et al. · International Journal of Case Reports and Images · 2
PDF
536 Bevacizumab in cervical cancer – the experience of a comprehensive cancer center in northern Portugal
2021 · A. Vaz-Ferreira, S. Monteiro, et al. · International Journal of Gynecological Cancer · 1
PDF
1515P Aggressiveness and economic impact of advanced cancer treatment near the end of life
2020 · I.A. Pereira, J. Gomes, et al. · Annals of Oncology · 1
Impact of sepsis and organ dysfunction on cancer patients' mortality
2016 · F.M. Pereira, S. Alves, et al. · Annals of Oncology · 1
PDF
Phase 1 Dose Escalation and Cohort Expansion Study of the Safety of Intrathecal Trastuzumab in Her2 Positive Parenchymal Brain Metastatic Breast Cancer: Trial Protocol
2014 · J. Savva-Bordalo, A.C.F. Rodrigues, et al. · Annals of Oncology · 1
Correction: Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts
2026 · Inês Guerra de Melo, Valéria Tavares, et al. · Molecular Biology Reports
PDF
Central nervous system metastases in gynecologic cancers: Real-world outcomes and prognostic factors.
2026 · Bruno Soares, Diana Mata, et al. · Journal of Clinical Oncology
PDF
Heparanase (HPSE) genetic variants as prognostic indicators in ovarian cancer: evidence from discovery and validation cohorts
2026 · Inês Guerra de Melo, Valéria Tavares, et al. · Molecular Biology Reports
Po115 Real World Effectiveness of Everolimus-based Therapy in Hormone-receptor-positive Metastatic Breast Cancer After Progression on Cdk4/6 Inhibitor
2023 · Joana Savva-Bordalo, Cristina Oliveira, et al. · The Breast
PDF
Works count: 42
Citation count: 368
H-index: 9
I10-index: 9
Year
Topic
Type